- Forums
- ASX - By Stock
- PAA
- Ann: Extension Study Begins, Analysis Suggests Survival Benefit
Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-15
-
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.5¢ |
Change
0.010(4.88%) |
Mkt cap ! $95.68M |
Open | High | Low | Value | Volume |
21.5¢ | 22.0¢ | 21.5¢ | $387.7K | 1.801M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19000 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 95000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19000 | 0.215 |
5 | 294678 | 0.210 |
5 | 257125 | 0.205 |
15 | 540770 | 0.200 |
8 | 267463 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 95000 | 3 |
0.225 | 2084 | 1 |
0.230 | 79360 | 3 |
0.240 | 134752 | 2 |
0.245 | 270545 | 4 |
Last trade - 14.25pm 15/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online